Arrowhead Pharmaceuticals (ARWR) Treasury Shares (2012 - 2026)

Arrowhead Pharmaceuticals (ARWR) has 14 years of Treasury Shares data on file, last reported at $5.9 million in Q1 2025.

• Quarterly Treasury Shares changed N/A year-over-year to $5.9 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $5.9 million (changed N/A YoY) and the FY2024 annual result came in at $4.9 million, up 15.84% from the prior year.
• Treasury Shares held at $53.2 million in Q1 2026, from $53.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.9 million in Q1 2025 to a low of $1.7 million in Q2 2023.
• A 5-year average of $3.6 million and a median of $3.8 million in 2021 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares plunged 62.23% — and 2024, when it surged 66.24%.
• Tracing ARWR's Treasury Shares over 2 years: stood at $53.2 million in 2025, then changed by 0.0% to $53.2 million in 2026.
• The last three Treasury Shares figures came in at $53.2 million (Q1 2026), $53.2 million (Q4 2025), and $53.2 million (Q3 2025), per Business Quant data.